Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Potential Benefits & Considerations Research Observations (Educational / Research Context) May support liver detoxification and conjugation pathways associated with cellular clearance processes
Based on animal research, potential interactions may occur with dopamine-affecting medications (Parkinson's drugs), blood pressure medications, anticoagulants (blood thinners), and immunosuppressants
Gently massage into the scalp to ensure deep penetration
SS31 is currently FDAapproved only for Barth syndrome under the brand name Forzinity
Subcutaneous Protocol Table (1 Injection Daily or Every Other Day) (Assumes 200 mg/mL concentration 1 unit = 2 mg on a U-100 syringe) One vial (~1500 mg) lasts about 78 injections using this protocol
